<DOC>
	<DOCNO>NCT02075138</DOCNO>
	<brief_summary>Grass pollen allergen universally recognise major cause allergic disease human , include asthma , allergic rhinitis , conjunctivitis dermatitis . The purpose current study evaluate allergy symptom allergy medication subject grass-related rhinoconjunctivitis .</brief_summary>
	<brief_title>Grass Observational Study</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>History moderate severe rhinoconjunctivitis consistent allergy grass least 2 year . Forced Expiratory Volume 1 Second ( FEV1 ) least 70 % predict value personal best available Screening Visit . Perennial Rye grass Timothy grassspecific IgE ≥ 0.35 kU/L measure ImmunoCAP® . Positive skin prick test Perennial Rye grass Timothy grass allergen Positive skin prick test ≥ 5 mm confounding , coexist seasonal allergen likely present preseason baseline grass pollen period . Medical record symptomatic perennial allergic rhinitis and/or asthma positive skin test ≥ 5 mm due perennial allergen subject regularly expose ( mould , dust mite , cockroach , animal dander ) avoid course study . Previous immunotherapy treatment grass allergen 1 month within 5 year prior screen . Subjects treat nongrass license allergen immunotherapy extract nongrass investigational immunotherapy 1 month within 1 year .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>